论文信息 - In Vitro and In Vivo Characterization of the Non-peptide NK3 Receptor Antagonist SB-223412 (Talnetant): Potential Therapeutic Utility in the Treatment of Schizophrenia - 字舞流文

In Vitro and In Vivo Characterization of the Non-peptide NK3 Receptor Antagonist SB-223412 (Talnetant): Potential Therapeutic Utility in the Treatment of Schizophrenia

C. Davies | J. Hagan | J. Kew | C. Scott | E. Southam | M. Wood | D. Pemberton | J. Watson | L. Dawson | G. Murkitt | J. Gartlon | Declan Jones | Gareth A. Jones | J. Cluderay | R. Foxton | R. D. L. Flor | G. A. Jones | Katherine J Cato